Literature DB >> 363191

Clinical trial methodology.

R Peto.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 363191

Source DB:  PubMed          Journal:  Biomedicine        ISSN： 0300-0893


× No keyword cloud information.
  24 in total

1.  Assessment of evidence versus consensus or prejudice.

Authors:  R West
Journal:  J Epidemiol Community Health       Date:  1992-08       Impact factor: 3.710

2.  Emotion and empiricism.

Authors:  D M Chaput de Saintonge
Journal:  Br Med J       Date:  1979-03-10

3.  Proposal for ethical standards in therapeutic trials.

Authors:  P Arpaillange; S Dion; G Mathe
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-28

4.  Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients. A meta-analysis.

Authors:  P Nony; J P Boissel; M Lievre; A Leizorovicz; M C Haugh; S Fareh; B de Breyne
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Statistics in question. Assessing methods--art of significance testing.

Authors:  S M Gore
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-29

6.  Statistics in question: assessing clinical trials--design II.

Authors:  S M Gore
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06

7.  Does exposure to extremely low frequency magnetic fields produce functional changes in human brain?

Authors:  F Capone; M Dileone; P Profice; F Pilato; G Musumeci; G Minicuci; F Ranieri; R Cadossi; S Setti; P A Tonali; V Di Lazzaro
Journal:  J Neural Transm (Vienna)       Date:  2009-02-03       Impact factor: 3.575

8.  Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.

Authors:  Gabriela L Bravo; Albert B Poje; Iago Perissinotti; Bianca F Marcondes; Mauricio F Villamar; Ann M Manzardo; Laura Luque; Jean F LePage; Diane Stafford; Felipe Fregni; Merlin G Butler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-11-21       Impact factor: 3.568

9.  Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial.

Authors:  R P Morton; F Rugman; E B Dorman; P J Stoney; J A Wilson; M McCormick; A Veevers; P M Stell
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  Simultaneous inference on treatment effects in survival studies with factorial designs.

Authors:  Dan-Yu Lin; Jianjian Gong; Paul Gallo; Paul H Bunn; David Couper
Journal:  Biometrics       Date:  2016-03-17       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.